On Dec. 27, the Centers for Medicare and Medicaid Services (CMS) unveiled a Notice of Proposed Rulemaking (NPRM) on improvements to the Medicare Advantage and prescription drug programs. In a Feb. 13 comment letter, AMCP offers suggestions for strengthening CMS' Medication Therapy Management program, accessible format requirements, and approved formulary, as well as proposals to increase health equity in Medicare Advantage.
Where We Stand: The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Susan Cantrell, AMCP CEO, to discuss the significance of the recent passage of the Pre-approval Information Exchange (PIE) Act of 2022.
January 2023 News & Views: AMCP Applauds Congressional Passage of PIE Act; AMCP Welcomes Two New Affiliates; Congratulations to AMCP’s Newly Elected 2023-2024 Board of Directors.
December 2022 News & Views: AMCP 2023 Registration is Now Open; PIE Act Gains Bipartisan Momentum Ahead of End-of-Year Push; Submit Your Comments for Proposed AMCP Bylaws Amendments by Jan. 25; Access the Latest AMCP Learn Programs Today.
November 2022 News & Views: Guest Blog: Exploring Lessons Learned During the AMCP Summit on Addressing Health Disparities; A Simple Way To Safely Accelerate Patient Access To New Therapies; Celebrate the Best in Managed Care Pharmacy; Save the Date: GivingTuesday is Nov. 29.